Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Drug Resistance Updates (2021) Vol. 60, pp. 100788-100788
Open Access | Times Cited: 21

Showing 21 citing articles:

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
Qingfang Li, Zhihui Li, Ting Luo, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Yumin Wang, Yongming Chen, Junjing Zhang, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101018-101018
Open Access | Times Cited: 81
DrugMAP: molecular atlas and pharma-information of all drugs
Fengcheng Li, Jiayi Yin, Mingkun Lu, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1288-D1299
Open Access | Times Cited: 72
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma
Cheng Zhou, Zhangfu Yang, Bao‐Ye Sun, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 697-712
Open Access | Times Cited: 19
Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy
Sihui Yu, Hongyang Xiao, Li Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188946-188946
Closed Access | Times Cited: 17
Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment
Liyun Zhu, Danni Meng, Xu Wang, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 6, pp. 2481-2506
Closed Access | Times Cited: 23
A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis
Longyan Wang, Huiming Huang, Xingxing Li, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
HIF in Gastric Cancer: Regulation and Therapeutic Target
Mengqing Li, Li Guan, Xiaodong Yang, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4893-4893
Open Access | Times Cited: 17
Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
Viviana Vella, Angeliki Ditsiou, Anna Chalari, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 2
Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer
Jinge Zhang, Yuan Huang, Xing Tan, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112184-112184
Closed Access | Times Cited: 2
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
Michèle Salmain, Marie Gaschard, Milad Baroud, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4448-4448
Open Access | Times Cited: 7
Curcumin targets miR-134-5p to suppress the progression of colorectal cancer through regulating the CDCA3/CDK1 pathway
Fu Liu, Chongmei Zhu, Hui Ma, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 109-122
Closed Access | Times Cited: 5
Research Progress on Inhibitors of PI3K/Akt Signaling Pathway in the Treatment of Gynecological Malignant
萌倩 王
World Journal of Cancer Research (2024) Vol. 14, Iss. 01, pp. 35-40
Closed Access | Times Cited: 1
MGMT activated by Wnt pathway promotes cisplatin tolerance through inducing slow-cycling cells and nonhomologous end joining in colorectal cancer
Haowei Zhang, Qixin Li, Xiaolong Guo, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 6, pp. 100950-100950
Open Access | Times Cited: 1
NXPH4 mediated by m5C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation
Lei Yang, Jiawen Shi, Mingyang Zhong, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Immunocytochemistry-Based Detection of FOXO Isoforms in Human Cancer and Fibroblasts
Lucía Jiménez, Lucía Domínguez, Carlos Amenábar, et al.
Methods in molecular biology (2024), pp. 171-176
Closed Access | Times Cited: 1
Transcriptome Profiling of HCT-116 Colorectal Cancer Cells with RNA Sequencing Reveals Novel Targets for Polyphenol Nano Curcumin
Hewa Jalal Azeez, Francesco Neri, Mohammad Ali Hosseinpour Feizi, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3470-3470
Open Access | Times Cited: 6
Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives
Tobias Achu Muluh, Xiaohong Lu, Yan Zhang, et al.
Current Cancer Drug Targets (2022) Vol. 23, Iss. 4, pp. 251-264
Closed Access | Times Cited: 4
Effects of Different Forms of Anthocyanins on the Growth Inhibition and Gene Expression of Colorectal Cancer Cells
Weidong Liu, Siting Feng, Dou He, et al.
Journal of Food Biochemistry (2024) Vol. 2024, Iss. 1
Open Access
Kinome-wide synthetic lethal screen identifies PANK4 as modulator of resistance in glioblastoma
Viviana Vella, Angeliki Ditsiou, Anna Chalari, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top